Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia

BACKGROUND: HIV patients on antiretroviral therapy have shown elevated incidence of dyslipidemia, lipodystrophy, and cardiovascular disease (CVD). Most studies, however, focus on cohorts from developed countries, with less data available for these co-morbidities in Ethiopia and sub-Saharan Africa. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gleason, Rudolph L., Caulk, Alexander W., Seifu, Daniel, Parker, Ivana, Vidakovic, Brani, Getenet, Helena, Assefa, Getachew, Amogne, Wondwossen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411122/
https://www.ncbi.nlm.nih.gov/pubmed/25915208
http://dx.doi.org/10.1371/journal.pone.0117125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411122/
https://www.ncbi.nlm.nih.gov/pubmed/25915208
http://dx.doi.org/10.1371/journal.pone.0117125

Ejemplares similares